We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

FAPON

Fapon is a global IVD raw materials & one-stop solutions company offering 700+ reagent raw materials for the applicat... read more Featured Products: More products

Download Mobile App





Fapon Presents Comprehensive Range of One-Stop IVD Solutions

By LabMedica International staff writers
Posted on 04 Feb 2025
Print article
Image: Fapon is sharing the latest industry insights with global IVD professionals at Medlab Middle East 2025 (Photo courtesy of Fapon Biotech)
Image: Fapon is sharing the latest industry insights with global IVD professionals at Medlab Middle East 2025 (Photo courtesy of Fapon Biotech)

Fapon Biotech (Dongguan, China) is showcasing its comprehensive one-stop IVD solutions and sharing the latest industry insights with its global partners at Medlab Middle East 2025. Leveraging its cutting-edge technologies and vast industry experience, Fapon has introduced its technology transfer and local manufacturing services to best underscore its commitment to enhancing local IVD industry development.

At the exhibition, Fapon is presenting a range of IVD solutions covering a wide spectrum of technology applications, including chemiluminescence immunoassay (CLIA), biochemistry, next-generation sequencing (NGS), polymerase chain reaction (PCR), lateral flow assay (LFA), and fluorescence immunoassay (FIA) for both clinical diagnostic laboratories and point-of-care testing (POCT) scenarios. Leveraging its strong foundation in IVD technologies, Fapon integrates open-system instruments, reagent services, and raw materials into One-stop IVD solutions. This approach ensures reliable, versatile, and seamless services for its IVD partners, especially local IVD companies and distributors that are establishing or expanding their own IVD production lines. Ultimately, these efforts benefit local hospitals and patients. Fapon's goal is to elevate the product portfolios of global IVD manufacturers and reduce their time-to-market through technology transfer and local manufacturing.

Fapon's CLIA and biochemistry product lines exemplify its expertise in One-stop IVD solutions. Its CLIA One-stop solution includes the Shine i-series open-system CLIA analyzers for low- to ultra-high-throughput testing, alongside over 80 reagent services for assays such as vitamin D, NT-proBNP, hs-cTnI, and PCT, and core IVD raw materials. Fapon is able to provide one-stop CLIA products and services from development, evaluation/registration, and QMS construction to after-sales. In addition, Fapon's biochemistry One-stop solution offers matching antibodies, antigens, latex particles, coupling procedures, and biochemistry analyzers, enabling its partners to successfully develop their IVD tests in a short time. Collectively, they demonstrate Fapon's commitment to advancing diagnostic technologies and customization services to meet the localization needs of the IVD manufacturers. Fapon's PCR one-stop solution can provide POCT instruments that can provide results in as fast as 30 minutes, along with customized reagent services. Fapon's FIA one-stop solution can offer multiple analyzers and reagents for over 40 types of diseases.

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Gold Member
Troponin T QC
Troponin T Quality Control
New
Toxoplasma Rapid Test
Toxo IgG/IgM Rapid Test Kit
New
Urine Drug Test
Instant-view Propoxyphene Urine Drug Test

Print article

Channels

Molecular Diagnostics

view channel
Image: RT-QuIC Prion, CSF is the only definitive antemortem clinical test of its kind that doesn’t involve a brain biopsy (Photo courtesy of Mayo Clinic)

CSF Test Distinguishes Prion Disease from Other Causes of Rapidly Progressive Dementia

Rapidly progressive dementias are a category of dementia where patients experience a swift decline from the onset of symptoms to losing functional independence, typically within two years.... Read more

Immunology

view channel
Image: New insights into preterm infant immunity could inform care (Photo courtesy of 123RF)

New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood

Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more

Pathology

view channel
Image: The Results Manager System (Photo courtesy of QuidelOrtho)

Informatics Solution Elevates Laboratory Efficiency and Patient Care

QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.